TRBJ2-6
T cell receptor beta joining 2-6
Also known as: TJB26_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- A0A0A0MT70
- Gene
- TRBJ2-6
- Canonical length
- 17 aa
- Protein class
- Predicted intracellular proteins, T-cell receptor genes
- Quaternary structure
- Homodimer
OverviewNCBI Gene
No narrative summary is available for TRBJ2-6 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
17 residues, UniProt reviewed canonical sequence.
>A0A0A0MT70|TRBJ2-6
1 SGANVLTFGA GSRLTVLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRBJ2-6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- spleen: 23 nTPM
- lymph node: 22 nTPM
- appendix: 21 nTPM
- stomach: 10 nTPM
- duodenum: 9.7 nTPM
- small intestine: 9.7 nTPM
Single-cell type
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
- alveolar cells type 2: 0 nCPM
- astrocytes: 0 nCPM
Immune cell
- MAIT T-cell: 214 nTPM
- T-reg: 199 nTPM
- memory CD8 T-cell: 163 nTPM
- naive CD4 T-cell: 158 nTPM
- memory CD4 T-cell: 129 nTPM
- gdT-cell: 90 nTPM
Brain region
- thalamus: 7.7 nTPM
- cerebral cortex: 6.9 nTPM
- white matter: 4.4 nTPM
- basal ganglia: 3.8 nTPM
- midbrain: 2 nTPM
- pons: 1.7 nTPM
OntologyGO
Biological processes
Cellular components
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRBJ2-6 as an antibody target. Whether an autoantibody or antibody against TRBJ2-6 could matter depends on whether native TRBJ2-6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRBJ2-6 is annotated at the cell surface, where native TRBJ2-6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TRBJ2-6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...